J&J lose bid to dismiss opioid crisis lawsuit in Okhlahoma

Organisation: Position: Deadline Date: Location:

An ongoing lawsuit against Johnson & Johnson for its part in the opioid crisis will continue after the company’s effort to have the case dismissed was denied by a judge, reports CNN. Cleveland County District Judge Thad Balkman denied a motion to toss the lawsuit, which accuses Johnson & Johnson and its subsidiaries of creating a public nuisance and costing the state of Oklahoma billions of dollars.

Oklahoma attorney general Mike Hunter told the court during proceedings that 4,653 Oklahomans died of unintentional overdoses involving prescription opioids from 2007 to 2017, and that there were more than 28,000 admissions for opioid and heroin treatment through state services from 2012 to 2018.

As a result, the state has presented a $17.5bn abatement plan over 30 years to fix the opioid epidemic.

The report says last week Johnson & Johnson filed a motion to end the case, saying that the company was made a “scapegoat” in the lawsuit. In the motion, lawyers called the state’s effort a “slew of illogical, legally defective theories far outside the bounds of Oklahoma precedent.”

Brad Beckworth, one of the lead attorneys for the state of Oklahoma, called the motion to dismiss a public relations stunt on the part of Johnson & Johnson and said the governor and other state leaders would “stand arm in arm with us” knowing that “we are doing the right thing under Oklahoma law.”

The state has rested its case after calling 28 witnesses over six weeks.

The report says Oklahoma is just one of several states that has sued drug makers including Johnson & Johnson, Purdue Pharma, Teva Pharmaceuticals and other companies for their role in the opioid crisis.

The state has already reached settlements with two other opioid drugmakers: a $270m settlement with Purdue Pharma, the makers of OxyContin, and an $85m settlement with Teva Pharmaceuticals, one of the world’s largest makers of generic drugs.

The report says following the denial, John Sparks, Oklahoma counsel for Janssen Pharmaceuticals Inc (a subsidiary of Johnson & Johnson), released a statement saying in part: “Despite the complexity of the problem (of the opioid crisis), the State of Oklahoma is attempting to have Janssen alone pay for extraordinary government spending without offering evidence that our companies were the cause of the state’s opioid crisis.”

The report says the company believes it did everything it was supposed to do as a manufacturer of prescriptions. “The State’s over-reaching interpretation of the statute is unsustainable and will force the State into uncharted legal waters long after this case is decided,” Sparks said.

CNN report

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.